Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities

被引:145
作者
Guan, Qi [1 ]
Han, Chunming [1 ]
Zuo, Daiying [2 ]
Zhai, Min'an [1 ]
Li, Zengqiang [2 ]
Zhang, Qian [1 ]
Zhai, Yanpeng [1 ]
Jiang, Xuewei [2 ]
Bao, Kai [1 ,3 ,4 ]
Wu, Yingliang [2 ]
Zhang, Weige [1 ]
机构
[1] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China
[3] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA 02215 USA
基金
中国国家自然科学基金;
关键词
Synthesis; Antiproliferative activity; Tubulin; Benzimidazole carbamates; Indole; Docking; IN-VITRO; BETA-TUBULIN; BINDING-SITE; CANCER; DESIGN; INHIBITORS;
D O I
10.1016/j.ejmech.2014.09.071
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel benzimidazole carbamates bearing indole moieties with sulphur or selenium atoms connecting the aromatic rings were synthesised and evaluated for their antiproliferative activities against three human cancer cell lines (SGC-7901. A-549 and HT-1080) using an MTT assay. Compounds 10a, 10b, 7a, 7b and 7f showed significant activities against these cell lines. The most potent compound in this series, 10a, was selected to investigate its antitumour mechanism. In addition, molecular docking studies suggested that compound 10a interacts very closely with the nocodazole docking pose through hydrogen bonds at the colchicine binding site of tubulin. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:306 / 315
页数:10
相关论文
共 21 条
[1]   Molecular basis for benzimidazole resistance from a novel β-tubulin binding site model [J].
Aguayo-Ortiz, Rodrigo ;
Mendez-Lucio, Oscar ;
Romo-Mancillas, Antonio ;
Castillo, Rafael ;
Yepez-Mulia, Lilian ;
Medina-Franco, Jose L. ;
Hernandez-Campos, Alicia .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2013, 45 :26-37
[2]   Towards the identification of the binding site of benzimidazoles to β-tubulin of Trichinella spiralis: Insights from computational and experimental data [J].
Aguayo-Ortiz, Rodrigo ;
Mendez-Lucio, Oscar ;
Medina-Franco, Jose L. ;
Castillo, Rafael ;
Yepez-Mulia, Lilian ;
Hernandez-Luis, Francisco ;
Hernandez-Campos, Alicia .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2013, 41 :12-19
[3]  
De Brabander M., 1976, CHEMOTHERAPY, V8, P121, DOI [10.1007/978-1-4613-4352-3_21, DOI 10.1007/978-1-4613-4352-3_21]
[4]   Arylthioindoles, potent inhibitors of tubulin polymerization [J].
De Martino, G ;
La Regina, G ;
Coluccia, A ;
Edler, MC ;
Barbera, MC ;
Brancale, A ;
Wilcox, E ;
Hamel, E ;
Artico, M ;
Silvestri, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6120-6123
[5]   Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4 [J].
Guan, Qi ;
Yang, Fushan ;
Guo, Dandan ;
Xu, Jingwen ;
Jiang, Mingyang ;
Liu, Chunjiang ;
Bao, Kai ;
Wu, Yingliang ;
Zhang, Weige .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 :1-9
[6]   Discovery of novel Benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors [J].
Hasegawa, Masaichi ;
Nishigaki, Naohiko ;
Washio, Yoshiaki ;
Kano, Kazuya ;
Harris, Philip A. ;
Sato, Hideyuki ;
Mori, Ichiro ;
West, Rob I. ;
Shibahara, Megumi ;
Toyoda, Hiroko ;
Wang, Liping ;
Nolte, Robert T. ;
Veal, James M. ;
Cheung, Mui .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) :4453-4470
[7]   CATALYTIC REDUCTION OF AROMATIC NITRO-COMPOUNDS WITH HYDRAZINE IN PRESENCE OF IRON(III) CHLORIDE AND ACTIVE CARBON [J].
HIRASHIMA, T ;
MANABE, O .
CHEMISTRY LETTERS, 1975, (03) :259-260
[8]   Practical methodologies for the synthesis of indoles [J].
Humphrey, Guy R. ;
Kuethe, Jeffrey T. .
CHEMICAL REVIEWS, 2006, 106 (07) :2875-2911
[9]   Triselenium dicyanide from malononitrile and selenium dioxide. One-pot synthesis of selenocyanates [J].
Kachanov, AV ;
Slabko, OY ;
Baranova, OV ;
Shilova, EV ;
Kaminskii, VA .
TETRAHEDRON LETTERS, 2004, 45 (23) :4461-4463
[10]   Targeting Established Tumor Vasculature: A Novel Approach to Cancer Treatment [J].
Kelland, Lloyd R. .
CURRENT CANCER THERAPY REVIEWS, 2005, 1 (01) :1-9